If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,114.00    -4.00 (-0.36%)
Bid:
1,112.00
Ask:
1,118.00
Spread: 6.00 (0.54%)
Market Cap: £381.40m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

8 Nov 2017 07:00

RNS Number : 8493V
Craneware plc
08 November 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

AGM Statement

 

8 November 2017 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 2pm. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

"We have experienced a positive start to trading in the first four months of the year, adding to the recent announcement of the $6m contract win extending the scope of our solutions within an existing customer. In June, we launched Trisus Claims Informatics, the first product on our cloud-based Trisus platform, to which we have seen a positive market response. In addition, we are seeing very encouraging results for the early adopters of our Trisus Cost Analytics Resource Efficiency product, which is currently under development within Craneware Healthcare Intelligence.

 

"The sales activity and the early product successes demonstrate how we are benefiting from our ongoing investments in our Value Cycle product suite, ensuring we have the solutions that provide insight into key areas of hospital operations, expanding our market opportunity and increasing our strategic value within our market.

 

"Our leadership in this area has further strengthened Craneware's position as a trusted partner for US healthcare organisations as they look to solve the challenges of the new value based reimbursement models.

 

"This positive impact of the Value Cycle on current sales and underlying pipelines combined with the high levels of revenue visibility and significant cash reserves, means we are well positioned to continue to execute on our growth strategy."

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

Hilary Buchanan

George Sellar

Robyn Fisher

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBCBDBGGGBGRR
Date   Source Headline
22nd Apr 20104:08 pmRNSHolding(s) in Company-Amendment
22nd Apr 20102:27 pmRNSHolding(s) in Company
21st Apr 20103:41 pmRNSDirectors Shareholding
21st Apr 20107:00 amRNSReseller Agreement with Premier
15th Apr 20104:12 pmRNSBlocklisting Interim Review
5th Mar 201011:02 amRNSDividend Currency Election
22nd Feb 20107:01 amRNSContract Win
22nd Feb 20107:00 amRNSInterim Results
4th Feb 20105:17 pmRNSHolding(s) in Company
25th Jan 201012:49 pmRNSHolding(s) in Company
18th Jan 20107:00 amRNSTrading Update
23rd Dec 20097:01 amRNSGrant of Options
22nd Dec 20097:00 amRNSIntermountain Healthcare Selects Craneware
19th Nov 20093:11 pmRNSResult of AGM
19th Nov 20097:00 amRNSAGM Statement
6th Nov 20091:41 pmRNSDividend Currency Election
21st Oct 20092:46 pmRNSBlocklisting Interim Review
20th Oct 20097:00 amRNSNotice of AGM
1st Oct 200912:39 pmRNSPosting of Annual Report and Accounts
25th Sep 20097:00 amRNSContract Win
18th Sep 200911:51 amRNSDirector/PDMR Shareholding
7th Sep 20097:00 amRNSFinal Results
26th Aug 20097:00 amRNSNotice of Results
6th May 20097:00 amRNSDividend Currency Election
27th Apr 20097:00 amRNSAppointment of Non-Executive Director
16th Apr 200912:44 pmRNSBlocklisting Interim Review
14th Apr 20097:00 amRNSAgreement with US healthcare alliance
26th Mar 200911:01 amRNSDirector/PDMR Shareholding
26th Mar 20097:00 amRNSDividend Declaration
27th Feb 20092:43 pmRNSDirector Shareholding
23rd Feb 20097:00 amRNSInterim Results
11th Feb 20096:23 pmRNSHolding(s) in Company
29th Jan 20097:00 amRNSNotice of Results
13th Jan 20097:00 amRNSTrading Update and Contract Win
19th Nov 200811:10 amRNSHolding(s) in Company
13th Nov 20085:43 pmRNSHolding(s) in Company
7th Nov 20083:04 pmRNSDividend Currency Election
4th Nov 20087:00 amRNSAGM Statement
31st Oct 20081:43 pmRNSHolding(s) in Company
31st Oct 20081:42 pmRNSHolding(s) in Company
24th Oct 200811:28 amRNSBlocklisting Interim Review
13th Oct 20087:00 amRNSNotice of AGM
16th Sep 20085:20 pmRNSHolding(s) in Company
15th Sep 20083:58 pmRNSHolding(s) in Company
9th Sep 20087:01 amRNSAppointment of a Director
9th Sep 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSTrading Statement
26th Jun 20088:32 amRNSRe Contract
25th Jun 20083:51 pmRNSHolding(s) in Company
24th Jun 20088:34 amRNSContract with CHE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.